Glutamine Market Size - By Type (L-Glutamine, D-Glutamine), Form (Powder, Capsules & Tablets, Liquid), Application (Dietary Supplements, Pharmaceuticals, Sports Nutrition, Clinical Nutrition, Food and Beverages, Animal Nutrition), Source & Forecast, 2023

Glutamine Market Size - By Type (L-Glutamine, D-Glutamine), Form (Powder, Capsules & Tablets, Liquid), Application (Dietary Supplements, Pharmaceuticals, Sports Nutrition, Clinical Nutrition, Food and Beverages, Animal Nutrition), Source & Forecast, 2023 - 2032

Glutamine market size is expected to record 3.4% CAGR from 2023 to 2032, primarily due to the increased awareness of the importance of essential amino acid in various sectors. There is high awareness about nutritional supplements among athletes and fitness enthusiasts, who are turning to glutamine for its muscle recovery and immune system-boosting properties.

Furthermore, the rising health consciousness among consumers has led to a growing demand for dietary supplements that contain glutamine. According to the NCBI, in UK, the vitamin sales increased by 63% in March 2020. Similarly, the U.S. reported rise in demand for multivitamins as the sales reached 51.2% in the same year.

Glutamine market is divided based on type, form, source, application, and region.

The D-glutamine segment is predicted to witness substantial growth through 2032. D-glutamine, a naturally occurring stereoisomer of L-glutamine, has garnered considerable attention due to its applications in the pharmaceutical and food industries. It is characterized by its higher stability and superior bioavailability, making it an attractive option for various formulations. As the pharmaceutical and food industries continue to expand, the D-glutamine type segment is expected to flourish, catering to the evolving needs of these sectors.

The pharmaceuticals application segment is anticipated to observe significant growth over 2023-2032 as glutamine plays a vital role in the pharmaceutical industry, particularly in cell culture media and as an essential component for the formulation of parenteral nutrition products. Its role in supporting the immune system and facilitating tissue repair has made it a valuable ingredient in a variety of medications. As pharmaceutical R&D continue to advance, the demand for glutamine is anticipated to rise further in the coming years.

Europe glutamine market size will gain massive revenues by 2032, driven by factors such as a growing aging population, increased healthcare expenditure, and a strong pharmaceutical sector. Additionally, the European Food Safety Authority's (EFSA) recognition of certain health claims related to glutamine's role in the immune system has heightened its appeal in the region. With an emphasis on health and wellness, Europe is expected to continue its substantial contribution to the global glutamine market.